MTOR inhibition and erythropoiesis: Microcytosis or anaemia?

Nephrology Dialysis Transplantation

Volumn 27, Issue 2, 2012, Pages 537-541

  Diekmann, Fritz ^a,b   Rovira, Jordi ^a   Diaz Ricart, Maribel ^a   Arellano, Edgar Marcelo ^a,c   Vodenik, Barbara ^a   Jou, Josep Maria ^a   Vives Corrons, Joan Lluís ^a,d   Escolar, Gines ^a   Campistol, Josep M ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^d Red Cell Pathology Unit   (Spain)

Author keywords

anaemia; microcytosis; mTOR inhibitor; rapamycin; sirolimus

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; ERYTHROCYTE COUNT; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY TRANSPLANTATION; MALE; MEAN CORPUSCULAR VOLUME; MICROCYTOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCYTHEMIA; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT RESPONSE;

ANEMIA; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTE COUNT; ERYTHROCYTE INDICES; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; HEMATOLOGIC DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, PARENTERAL; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; SIROLIMUS; STATISTICS, NONPARAMETRIC; TOR SERINE-THREONINE KINASES;

EID: 84856850359     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr318     Document Type: Article

References (15)

1. Shah N, Al-Khoury S, Afzali B et al. Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors. Transplantation 2006; 81: 1112
2. Pfeffer MA, Burdmann EA, Chen CY et al. TREAT Investigators. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361: 2019-2032
3. Augustine JJ, Knauss TC, Schulak JA et al. Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant 2004; 4: 2001
4. Ekberg H, Bernasconi C, Nöldeke J et al. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study. Nephrol Dial Transplant 2010; 25: 2004-2010
5. Friend P, Russ G, Oberbauer R et al. Incidence of anemia in sirolimustreated renal transplant recipients: the importance of preserving renal function. Transpl Int 2007; 20: 754
6. Derelanko MF. Determination of erythrocyte life span in F-344, Wistar, and Sprague-Dawley rats using a modification of the [3H] diisopropylfluorophosphate ([3H]DFP) method. Fundam Appl Toxicol 1987; 9: 271
7. KimMJ,Mayr M,PechulaMet al.Marked erythrocytemicrocytosis under primary immunosuppression with sirolimus. Transpl Int 2006; 19: 12
8. Diekmann F, Budde K, Oppenheimer F et al. Predictors of success in conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction. Am J Transplant 2004; 4: 1869-1875
9. Reitamo S, Spuls P, Sassolas B et al. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001; 145: 438
10. Maiorano A, Stallone G, Schena A et al. Sirolimus interferes with iron homeostasis in renal transplant recipients. Transplantation 2006; 82: 908
11. Augustine JJ, Rodriguez V, Padiyar A et al. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium. Transplantation 2008; 86: 548
12. Thaunat O, Beaumont C, Chatenoud L et al. Anemia after late introduction of sirolimus may correlate with biochemical parameters of a chronic inflammatory state. Transplantation 2005; 80: 1212
13. Sánchez Fructuoso A, Calvo N, Moreno MA et al. Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients. Transplant Proc 2007; 39: 2242
14. Sofroniadou S, Kassimatis T, Goldsmith D. Anaemia, microcytosis and sirolimus-is iron the missing link? Nephrol Dial Transplant 2010; 25: 1667
15. Diekmann F, Rovira J, Carreras J et al. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass. J Am Soc Nephrol 2007; 18: 2653-2660